How to Get Consistent, Defensible Cleaning Validation Results with the Veolia Sievers M9

The batch is ready. The vessel looks clean. But the documentation is not done, the QC queue is backed up and the equipment has been sitting idle waiting on analytical results.

This is the real cost of a slow or uncertain cleaning validation programme. Not the cost of the instrument. Not the complexity of the method. The cost is measured in hours of lost production, delayed releases and the quiet anxiety of knowing that if an inspector walked in right now, your data trail would not tell a clear and convincing story.

Total organic carbon (TOC) analysis exists precisely to eliminate that anxiety. When implemented correctly, it is one of the fastest, most regulator-friendly, and most operationally practical cleaning verification methods available. This article explains why so many labs are not using it that way and what it takes to change that.

What does a failed clean actually cost?

Most cleaning validation conversations start with the method. They should start with the consequence. A single failed clean in a pharmaceutical or food manufacturing facility does not just mean re-cleaning the vessel. It means halting production, quarantining potentially affected batches, initiating a deviation investigation, documenting the root cause, re-validating the cleaning cycle and demonstrating to QA that it will not happen again. In a worst-case scenario, that is days of downtime on a critical piece of manufacturing equipment.

The Chemetrix team has seen this play out in facilities relying on product-specific methods like HPLC for cleaning verification. When an unknown degradant or cleaning agent residue slips through undetected, the specific method offers no warning. TOC does. Because it measures the total organic carbon in a rinse or swab sample, it catches APIs, degradants, excipients and cleaning agents in a single analysis. There is no invisible contamination with a properly implemented TOC method.

The three most common operational pain points the Chemetrix team identifies in cleaning validation programmes are:

  • Poor worst-case selection. Labs test the wrong compound or the wrong surface area, which means their validation does not reflect real-world cleaning challenges.
  • Weak limit translation. There is a well-defined ppm requirement on paper, but nobody has converted it into an actionable TOC concentration limit for the instrument.
  • Inconsistent sampling. Swab technique varies between analysts, water baseline is not controlled and grab samples represent a single timepoint rather than a continuous view of the cleaning cycle.

These are workflow problems. Not instrument problems.

Why is TOC considered the gold standard for cleaning validation?

TOC analysis works by oxidising all organic residues in a sample and measuring the carbon dioxide produced. The result is a single, quantitative carbon concentration value that tells you, objectively, how much organic material remains on the equipment surface or in the final rinse.

This matters enormously in a regulated environment because it removes operator subjectivity from the result. There is no peak integration to argue about, no ghost peaks to investigate and no ambiguity about whether a signal is real or an artefact. The FDA has issued numerous warning letters specifically for HPLC data integrity failures, including failure to integrate peaks and inadequate investigation of unknown peaks. These problems are structurally unavoidable in product-specific methods because cleaning processes generate degradants and unexpected compounds that the specific method was never designed to detect.

TOC does not have this problem. It detects everything organic. That is not a liability. That is a feature. The regulatory acceptance of TOC for cleaning validation is well established. The US Pharmacopoeia, the US Food and Drug Administration and the European Medicines Agency all recognise TOC as an appropriate and compliant method for demonstrating equipment cleanliness. The FDA’s 2011 process validation guidance is particularly significant: the traditional practice of measuring a single API with a specific method is no longer considered compliant with FDA best practice, because it does not provide the process understanding the life cycle approach requires. TOC, as a non-specific method, measures both product-related and process-related residues as a function of carbon content, making it compliant with that guidance and giving a comprehensive view of cleanliness at every phase of the validation life cycle.

When sensitivity becomes a concern, it is worth reframing the question:

A TOC analyser is not too sensitive. It is appropriately sensitive. Sensitivity is exactly what guarantees that equipment is genuinely clean, not just clea

n enough to pass a method that was not looking for everything.

Is TOC actually cheaper than HPLC for cleaning validation?

The short answer is yes – in most cases, TOC is more cost-effective than HPLC, often delivering noticeable savings within the first year of implementation.

Here is what a realistic comparison looks like across the two approaches:

HPLC for cleaning validation requires a separate, validated method for each product. Method development is time-consuming and assumes that all potential interferents are fully understood. It cannot detect degradants or cleaning agent residues that fall outside the target compound. Laboratory workflow typically means grab samples are transported to the QC lab, queued for analysis and results returned hours later. Equipment sits idle during this time.

TOC for cleaning validation requires a single method that covers APIs, excipients, degradants and cleaning agents simultaneously. The Sievers M9 delivers results in two minutes in standard mode, or four seconds with the optional Turbo mode. The M9 Portable model can be taken directly to the manufacturing floor, samples can be analysed almost immediately after collection and equipment can be released faster.

The economic gains compound over time. Fewer out-of-specification investigations due to environmental or transcription errors, faster analyst throughput, reduced re-testing and the elimination of mobile phase preparation all contribute to a meaningfully lower total cost of running a cleaning validation programme.

Chemetrix Insight: “TOC almost always reduces total validation costs within the first year by accelerating batch release and reducing the frequency of re-testing. The instrument cost is recovered faster than most labs expect.”

How do you troubleshoot a TOC cleaning validation workflow that is not performing?

When TOC results are inconsistent or a cleaning validation programme is not delivering the confidence it should, the problem is almost never the analyser. Here is the hierarchy of where to look first.

Step 1: Check the water baseline. The carbon contribution of the rinse water itself must be established and controlled. If the water baseline is elevated or variable, every subsequent result will be unreliable. Low-TOC water and appropriate Sievers certified vials are the foundation of reproducible results.

Step 2: Review the swab technique. Analyst-to-analyst variability in swabbing is one of the most common sources of inconsistency in cleaning validation data. In published validation data using the Sievers M9, two different analysts achieved recovery values of 100% to 105.8% with RSD values below 2.1% for the same CIP-100 cleaning agent at multiple concentration levels, demonstrating that a well-standardised method is highly reproducible across operators. If your res

ults do not look like this, the method has not been standardised, not the instrument.

Step 3: Confirm the worst-case compound is correctly identified. Many facilities test the easiest-to-detect compound rather than the hardest-to-clean one. Worst-case selection should be based on solubility, toxicity and difficulty of removal, not analytical convenience.

Step 4: Verify the limit is correctly translated. A product limit expressed in ppm of compound is not directly equivalent to a TOC limit. The conversion requires multiplying by the percentage carbon in the chemical formula of the compound. For example, if a specific API limit is 10 ppm and the percentage carbon is 50%, the TOC limit is 5 ppm. This step is frequently skipped or done incorrectly.

Step 5: Consider the deployment. If equipment turnaround is the primary constraint, laboratory-based grab sample analysis may simply not be fast enough. At-line analysis with the M9 Portable or online analysis with the M9 On-Line can eliminate the QC queue entirely and enable real-time equipment release.

Practical resources:

  • Veolia Application Note: Validating the TOC Method for Cleaning Validation Applications in the Pharmaceutical Industry
  • Veolia Fact Sheet: Top 5 Secrets to a Successful Cleaning Validation Program
  • Veolia eBook: Total Organic Carbon for Cleaning Validation Programs
📌 Contact Chemetrix to request a workflow review of your current cleaning validation programme.

What makes the Veolia Sievers M9 the right instrument for pharmaceutical cleaning validation?

The Sievers M9 was not designed for a research scientist with unlimited time. It was designed for the QC technician who needs to verify that a vessel is clean, release the equipment and get back to supporting production. That distinction matters.

The Sievers Membrane Conductometric Detection method is what sets the M9 apart technically. Unlike instruments that use non-dispersive infrared (NDIR) detection, the Sievers gas-permeable membrane selectively passes only the CO₂ produced from the oxidation of organics. Acids, bases and halogenated compounds, which are frequently present in pharmaceutical cleaning processes, are prevented from interfering with the measurement. This delivers selectivity and precision in exactly the sample matrices where cleaning validation is performed.

The M9 comes in three configurations to match any deployment need:

  • M9 Laboratory: For QC labs running high volumes of rinse and swab samples, with optional Autosampler for 24-plus hours of unattended analysis
  • M9 On-Line: Attached directly to a CIP skid for continuous real-time monitoring and automated equipment release without any manual sampling
  • M9 Portable: Lightweight and IP-21 rated for at-line use on the manufacturing floor, supporting both rinse and swab samples with optional Turbo mode

Across all three configurations, the M9 delivers a measurement range of 0.03 ppb to 50 ppm with precision below 1% RSD and accuracy of plus or minus 2% or plus or minus 0.5 ppb, whichever is greater. Calibration is typically stable for 12 months. Maintenance requires just a few hours per year. The instrument comes pre-calibrated from the factory and can be prepared for analysis in under one hour.

For regulated environments, the optional DataGuard software provides full 21 CFR Part 11 and Annex 11 compliance, with a secured audit trail, user-level access controls and data that cannot be modified or deleted. The M9 also simultaneously reports TOC, inorganic carbon and conductivity from a single sample, giving three discrete data points that can be used together to identify root cause, optimise cleaning cycles and support OOS investigations.


Practical resources:

  • Veolia Application Note: Validating the TOC Method for Cleaning Validation Applications in the Pharmaceutical Industry
  • Veolia Fact Sheet: Top 5 Secrets to a Successful Cleaning Validation Program
  • Veolia eBook: Total Organic Carbon for Cleaning Validation Programs
📌 Contact Chemetrix to request a workflow review of your current cleaning validation programme.

Stop blaming the instrument and fix the workflow

The most common story Chemetrix hears is some version of this: “We tried TOC. It did not work for us.” After closer investigation, the story is almost always the same. The water baseline was not controlled. The worst-case compound had not been properly identified. The limit had not been correctly translated from ppm of compound to a TOC concentration. The sampling was inconsistent between analysts.

The instrument was fine. The workflow was not.

Chemetrix does not just supply a Sievers M9 and move on. The partnership Chemetrix offers is built around making sure the workflow is right before the instrument is even switched on, and that the team running it has the knowledge to trust the results it produces.

This means three specific things in practice:

  • Worst-Case Selection Support: Helping your team identify which compound, which equipment surface and which cleaning cycle represents the genuine worst case for your process, so your validation is defensible under inspection.
  • Limit Translation: Converting your existing acceptance criteria into actionable TOC concentration limits, accounting for the percentage carbon in the chemical formula and the sampling method used.
  • Sampling Standardisation: Establishing consistent swab technique, water baseline controls and vial selection across your team so that analyst-to-analyst variability is eliminated as a source of OOS investigations.

When results are consistent, compliance follows. That is not a slogan. It is the operating principle of a cleaning validation programme that works.

Conclusion

Cleaning validation does not have to be the bottleneck it has become in many facilities. The science is straightforward. The regulatory acceptance is well established. The instrument is reliable, automated and designed for QC technicians rather than research scientists.

The three things to take away from this article:

  • TOC catches what specific methods miss. APIs, degradants, excipients and cleaning agents are all detected in a single analysis, making it inherently more comprehensive than HPLC for cleaning verification.
  • Most TOC problems are sampling and workflow problems. Controlling the water baseline, standardising swab technique and correctly translating limits will resolve the vast majority of analytical inconsistencies.
  • The Sievers M9 is built for production environments. With two-minute analysis time, optional Turbo mode at four seconds, three simultaneous data outputs and 21 CFR Part 11 compliance, it is designed to release equipment and get out of the way.

The Sievers M9 delivers consistent, defensible proof that cleaning works. Chemetrix makes sure your workflow does too.

Ready to stop guessing and start releasing?

📩 Contact the Chemetrix team to book a cleaning validation workflow audit or arrange a Sievers M9 demonstration: chemetrix.co.za

The Intelligent Lab: How AI and Advanced Metabolomics are Redefining Scientific Discovery

The pace of scientific discovery is no longer governed solely by the physical limits of manual experimentation. We are currently witnessing a shift that is as transformative as the invention of the microscope itself. Artificial Intelligence (AI) and advanced metabolomics are reshaping how science is conducted, moving research from a “trial-and-error” model to a predictive, data-driven discipline. By combining high-resolution analytical hardware with machine learning, laboratories can now solve complex biological challenges – such as developing animal-free culture media – with unprecedented speed.

The complexity of the modern workflow

In the fast-evolving landscape of biopharmaceuticals and cell biology, the reliance on traditional methods often leads to significant hurdles. For decades, the industry has relied on fetal bovine serum (FBS) to supplement cell culture media, despite its high costs, ethical concerns, and inherent inconsistency.

Many lab teams find themselves buried under mountains of raw data from complex matrices, struggling to identify which specific molecular components actually drive performance.

When dealing with undefined raw ingredients, such as plant and microbial extracts, understanding chemical composition is critical to ensuring batch-to-batch reproducibility and process continuity when scaling.

From raw peaks to actionable insights

The challenge in modern labs isn’t a lack of data; it is the complexity of interpreting high-dimensional datasets. Manual analysis of thousands of formulations is no longer feasible. As regulatory requirements for biologics become more stringent, the demand for defined, reproducible, and regulatory-compliant media has grown.

Advanced metabolomics provides the molecular profiling required to qualify raw materials, while AI handles the broad combinatorial screening. This synergy allows researchers to tailor media composition to specific cell lines, improving yield and efficiency across the drug development lifecycle.

Optimising media with LC/Q-TOF

To solve the media development challenge, Chemetrix supports the implementation of untargeted metabolomic workflows. By utilising the Agilent 6545 LC/Q-TOF, labs can perform detailed molecular characterisation of both raw materials and finished formulations.

How Chemetrix assists:

Our specialists help your team establish metabolomic workflows that provide detailed molecular information for R&D. We assist in identifying “critical component targets” – biomarkers of performance – that become your QC benchmarks. By linking these molecular features to cellular outcomes, we help you replace inconsistent serums with precise, scalable,
animal-free alternatives.

Agilent 6545 LC/Q-TOF

Predictive productivity

Efficiency in the modern lab is increasingly driven by smart automation. The Agilent Infinity III LC Series is designed to address the operational risks that lead to downtime and lost samples through integrated AI-powered solutions.

How Chemetrix assists:

Chemetrix provides the technical expertise to integrate these platforms into your existing regulatory-ready environment. The Infinity III offers predictive analytics and real-time alerts to pre-empt operational failures. We assist in configuring these advanced informatics platforms so that your lab can handle complex workflows with greater precision. This shift to an automated, AI-enabled system allows your staff to focus on high-value data interpretation rather than routine manual monitoring.

Compressing development from years to months

The shift toward AI-guided development marks a new paradigm in biological optimisation. By continuously training algorithms with high-quality experimental data, each project makes the platform more intelligent. This iterative process has the power to compress development cycles that once took years into just a few months. When molecular characterisation is linked directly to cellular performance, the result is a more resilient supply chain and a faster time-to-market for novel therapies.

Optimising the path to discovery

The integration of AI and separation science is no longer a luxury; it is the foundation for the next generation of bioprocess innovation. At Chemetrix, we provide the local application expertise and technical support required to navigate these digital transformations.


Your action plan

Identify a workflow in your lab that currently relies on undefined ingredients or manual screening. Contact a Chemetrix specialist today for a workflow audit. We will help you leverage advanced metabolomics and AI-powered instrumentation to ensure your processes are reproducible, compliant, and ready for the future of biomanufacturing.

Beyond the Bench: Why Partnership is the Critical Component in Pharmaceutical Analysis

In the pharmaceutical industry, the most valuable asset isn’t the active ingredient or the patented molecule – it is the integrity of the data that proves it works. In a sector governed by uncompromising regulatory standards, a laboratory’s reputation is built on its ability to produce consistent, compliant, and accurate results. However, as drug formulations grow more complex and detection limits move lower, many laboratories find that having the right equipment is only half the battle. The real challenge lies in the support system that keeps that equipment performing within the narrowest of margins.

At Chemetrix, we have been an authorised Agilent distributor in Southern and East Africa for decades. While our heritage is diverse, our commitment to the pharmaceutical sector is foundational. We don’t just supply instruments; we provide the technical scaffolding that allows pharmaceutical analysts to move from a raw sample to a validated report with total confidence.

Why great hardware isn’t enough

One of the most persistent challenges in the pharmaceutical workflow is the transition from a concept to a robust, validated method. It is a common misconception that high-end instrumentation automatically guarantees ease of use. In reality, pharmaceutical analysts often struggle with the “blank space” between unboxing an instrument and running their first compliant sample.

Whether you are identifying trace impurities, performing stability testing, or conducting complex bioanalysis, the method development phase is often where projects stall. A method that works in a controlled environment can fail in a high-throughput production setting if it hasn’t been stress-tested for robustness. This leads to a reactive cycle of troubleshooting and re-validation, which drains resources and delays time-to-market.

Navigating a shifting regulatory landscape

Data integrity is the non-negotiable cornerstone of the pharmaceutical industry. Global research shows that 90% of pharmaceutical professionals agree that reliable instruments are the single most important factor for a successful workflow. This is because, in this sector, a failure in reliability is a failure in compliance.

The pressure to process more samples while maintaining absolute adherence to 21 CFR Part 11 and EudraLex Annex 11 is immense. Without a partner who understands the nuances of IQ/OQ (Installation and Operational Qualification) and ongoing maintenance, labs risk falling into the “efficiency gap.” This is where sophisticated instruments sit underutilised because the method is too temperamental or the staff lack the specific training required to navigate the software’s compliance features.

Mastery of complex matrices with Agilent LC/MS

For laboratories tackling the most demanding pharmaceutical applications – such as nitrosamine analysis or impurity profiling– Agilent’s LC/MS solutions are globally recognised as the definitive standard. These systems provide the sensitivity and specificity required to detect analytes at levels that were previously unimaginable.

However, the “Chemetrix Edge” lies in how we support this technology. We recognise that method development for LC/MS is a specialised skill. Our support department acts as an extension of your own team, providing on-site assistance to help you develop, optimise, and troubleshoot your pharmaceutical methods. By leveraging our local application expertise, you can reduce the time spent in method development and ensure that your LC/MS system is performing at its peak from day one.

Driving throughput with the Agilent 1290 Infinity III LC

The workhorse of any modern pharmaceutical lab is the Liquid Chromatograph, and the Agilent 1290 Infinity III LC is engineered specifically for high-throughput environments. It is designed to handle the everyday pressures of pharmaceutical analysis with ultra-low carryover and exceptional pressure stability.

Chemetrix supports this hardware through a comprehensive service programme that goes beyond simple repairs. We offer tailored preventive maintenance and rapid-response technical support to ensure your 1290 Infinity III stays in a qualified state. By integrating our service expertise with this robust hardware, we help labs eliminate the “time traps” of manual intervention. Our goal is to ensure your staff spend less time worrying about baseline
drift and more time focusing on high-value data interpretation.

Agilent 1290 Infinity III LC

The reward of proactive support

The transition from a reactive laboratory to a proactive one is transformative. When you partner with a specialist who understands pharmaceutical applications, the results are measured in more than just uptime. You gain the peace of mind that comes from knowing your methods are robust, your instruments are qualified, and your data is defensible.

Our most successful pharmaceutical partners are those who have moved away from viewing instrumentation as a commodity and have embraced it as a collaborative workflow. This partnership leads to faster validation cycles, fewer “Out of Specification” (OOS) investigations, and a laboratory team that is empowered by their technology rather than frustrated by it.

 


Take the next step in laboratory excellence

The road to an optimised pharmaceutical workflow doesn’t have to be a solitary one. Whether you are looking to expand your LC/MS capabilities or need to refine the efficiency of your current chromatography setup, the expertise you need is available locally.

Your Action Plan:

Identify your most temperamental method – the one that requires the most manual intervention or frequent re-runs. Contact a Chemetrix specialist today for a workflow audit. Let’s work together to resolve your method development challenges and ensure your lab is equipped for the future of pharmaceutical discovery.

From Manual to Mindful: Harnessing Automation and Intelligence in the Modern Laboratory

In the fast-paced world of laboratory science, the pressure to deliver results is relentless. Imagine this: it’s 4:00 PM on a Friday, and your high-priority sample run just failed due to a sudden instrument blockage. Or perhaps you are staring at a mounting backlog of samples, but your bench space is at its limit and your budget for new hires is non-existent.

If this sounds familiar, you aren’t alone. Modern laboratories are no longer just places of discovery; they are high-pressure environments where efficiency, accuracy, and cost-control must live in perfect harmony. But how do you scale your output without scaling your stress levels?

 

The growing pains of the modern lab

The challenges facing today’s lab managers are multifaceted. According to global research by Agilent, a staggering 45% of lab managers face significant pressure to process more samples, yet they are expected to do so without increasing operational costs.

Beyond volume, there is the hurdle of unplanned downtime. Around 75% of lab managers cite instrument maintenance and downtime as their biggest headache. In the pharmaceutical sector, this figure rises even higher, where 90% of professionals agree that reliable instruments are the single most important factor for a successful workflow. Add to this the physical constraints of small laboratory premises and the constant evolution of regulatory standards, and it is easy to see why many feel they are running to stand still.

 

 

Navigating the efficiency trap

When we talk about “lab efficiency,” we often think of speed. However, true efficiency is about data integrity and resource management. Many laboratories still rely on manual processes that are prone to human error, leading to costly re-tests.

Data shows that in many traditional setups, some lab instruments are only being utilised 35% of the time, while the rest of the day is lost to manual sample preparation, cleaning, or waiting for repairs.

 

This “efficiency gap” doesn’t just slow down research; it eats into the bottom line and delays life-changing products from reaching the market.

 

Automating the mundane with Chemetrix

One of the most effective ways to reclaim your time is through Lab Automation. Chemetrix positions itself as more than a supplier; we are a partner in your workflow. By identifying “time traps” in your daily routine – such as repetitive liquid handling or manual SPE (Solid Phase Extraction) – we can help you transition to a smarter way of working.

A standout solution in this space is the Agilent 1260 Infinity III LC System. This instrument is a workhorse designed for the “everyday” challenges of a busy lab. It allows you to mix and match modules with existing setups, meaning you don’t have to overhaul your entire lab to see an immediate boost in throughput. Chemetrix assists by providing the technical expertise to integrate these systems seamlessly, ensuring your staff are trained to focus on high-value data interpretation rather than the repetitive motion of pipetting.

 

Explore the modules:
Agilent 1260 Infinity III Diode Array Detector – Wide Range

Agilent 1260 Infinity II Multi-Angle Light Scattering Detector

 

Smarter analysis with the 8890 gas chromatograph

Maintenance shouldn’t be a game of “wait and see.” To combat the 75% of downtime caused by maintenance issues, Chemetrix recommends moving toward Instrument Intelligence.

 

The Agilent 8890 GC System is the gold standard for labs looking to eliminate guesswork. This instrument features built-in intelligence that monitors its own health, providing digital alerts for regular maintenance before a failure occurs. It even offers step-by-step instructions on-screen for common maintenance procedures.

 

When you partner with Chemetrix, you gain access to our “Support When You Need It” guarantee. Our experts don’t just deliver a box; we help you configure the 8890 to your specific applications – whether that’s environmental testing or complex chemical analysis – ensuring maximum uptime and a much higher return on investment.

 

Agilent 8890 GC System

 

From pressure to productivity: The power of partnership

The ultimate goal of any laboratory is to produce results that make a difference. When you move from a reactive “fix-it” mindset to a proactive, automated workflow, the results are transformative.

Imagine a lab where instruments “hum” along without intervention, where data integrity is guaranteed by digitisation, and where your team has the breathing room to innovate. This isn’t a futuristic dream; it is the reality for laboratories that have embraced smarter technology. By reducing manual intervention, you not only increase your sample capacity but also improve the morale of your team, allowing them to do the science they were actually trained for.

 

 

Take the first step towards a smarter lab

You don’t have to solve every challenge at once. Improving lab efficiency is a journey, and it starts with a single conversation. Whether you’re struggling with limited bench space, rising costs, or frustrating downtime, the team at Chemetrix is ready to listen.

Your next move: Why not audit your current workflow? Identify your biggest “time trap” and contact a Chemetrix expert today for a tailored consultation. Let’s work together to turn your laboratory challenges into your greatest competitive advantage.

 

Visit our website to explore our full range of analytical solutions or join one of our upcoming webinars to learn how to free your workflow from common time traps.

From Dust to Diamonds: How to Master Trace Metal Analysis in Modern Mining

In the high-stakes world of modern mining, the line between a profitable venture and a missed opportunity is thinner than ever. As high-grade ore deposits become harder to find, the industry is turning its attention to lower-grade materials and the vast potential of tailings reclamation. In this environment, the laboratory is no longer just a support service; it is the engine room of economic viability. When you are quantifying trace metals at ultra-low levels, even a microscopic speck of environmental dust can skew your data, potentially leading to false positives or masking the true value of a mineral deposit.

 

The mystery of the rising “Blanks”

If you’ve ever sat in front of your workstation wondering why your Blank and Background Equivalent Concentration (BEC) values are stubbornly high, you aren’t alone. It is a common frustration for geochemical analysts: your instrument is calibrated, your reagents are fresh, yet the background noise refuses to quieten down. These elevated values aren’t just technical nuisances; they directly impair your Limit of Quantification (LOQ). In a world where a $0.1\text{ g/t}$ difference in a gold tailings project can determine financial success, “noisy” data is a risk you cannot afford to take.

 

 

Understanding the noise: BEC and LOQ

To solve the problem, we first have to understand it. The BEC represents the total background signal of your analytical system – essentially the “noise” the instrument sees when no sample is present. When this noise is high, your instrument struggles to distinguish a genuine analyte signal from the background. This directly pushes up your LOQ, making it impossible to accurately quantify the lower concentrations that modern mining exploration demands. The root cause of these high values? It usually comes down to one single, persistent word: CONTAMINATION.

 

 

Clean up your act with expert training and standards

If your sample preparation isn’t meticulous, even the most advanced mass spectrometer will produce compromised results. Contamination is a silent thief that enters your workflow through water purity, reagent quality, and even the laboratory personnel themselves – common culprits include cosmetics, jewellery, and the powder in traditional gloves.

 

The Chemetrix Edge: We don’t just supply tools; we build expertise. Through the Chemetrix Lab Advisor, we provide your team with the specialised skills needed to identify and eliminate these “time traps”. By pairing this training with high-purity Inorganic Ventures Certified Reference Materials (CRMs), you ensure your calibration is built on a foundation of absolute purity.

 

Practical advice:

  • Stop the “Double-dip”: Never pipette directly from the stock bottle; transfer your working volumes into clean, secondary containers like pre-rinsed LDPE bottles.
  • Go gravimetric: Switch to weight-based (gravimetric) preparation. Mass doesn’t change with temperature, whereas volume does, leading to more reproducible and auditable results.

 

 

Technology that does the heavy lifting

While a clean bench is vital, the right hardware can act as your final line of defence against complex mineral matrices. Mining ores are notorious for their high levels of dissolved solids, which traditionally require extensive manual dilution – a process that introduces even more opportunities for human error and contamination.

 

The Chemetrix Edge: We recommend the Agilent 7850 / 7900 / 8900 ICP-MS series as the physical solution to these high-matrix challenges. These instruments are equipped with Ultra High Matrix Introduction (UHMI) technology, which uses clean Argon gas to “dilute” your sample aerosol before it even reaches the plasma.

 

Practical advice:

By using the Agilent 7850’s UHMI system, your lab can directly analyse samples containing up to $25\%$ total dissolved solids without manual liquid dilution. This not only saves hours of labour but practically eliminates the risk of dilution errors and reagent-born contamination.

 

 

From waste to wealth: The reward of precision

The ultimate goal of refining your workflow is simple: lower LOQs and higher confidence. When you master your contamination control, you unlock the ability to see value where others see waste. Successful tailings reclamation depends on this precision. By accurately monitoring recovery at trace levels, mining operations can turn legacy liabilities into profitable resources, contributing to a more sustainable and circular mining economy.

 

Take the next step towards cleaner data

Ready to lower your detection limits and boost your lab’s productivity? It starts with a partnership that understands your specific challenges.

Review your prep: Identify one source of potential contamination today (check those gloves!)

Audit your standards: Ensure your CRMs are matrix-matched to your ores for better accuracy.

Connect with Chemetrix: Let our team of scientists help you tailor a solution that combines Agilent’s world-class technology with practical, on-the-ground support.

Let’s advance science together. Contact Chemetrix today to explore how we can elevate your laboratory’s performance.

Are Your Drug Tests Predicting Clinical Reality?

A promising drug candidate passes every 2D cell culture test. The data looks perfect. Then it fails in clinical trials because it behaves completely differently in actual human tissue. This scenario plays out in pharmaceutical labs every day. The problem isn’t the science or the scientists. It’s the fundamental limitation of using 2D cell models to determine drug efficacy and toxicity when those models don’t adequately address the complexity of real world 3D tissues.

Ex vivo models and 3D samples like tumouroids and clinical biopsies are more biologically relevant than traditional 2D cell assays. But moving beyond traditional cell models requires tools designed specifically for cellular phenotyping of ex vivo samples.

When 2D models stop being enough

Every drug discovery researcher knows the frustration. Your 2D cell assay is optimised. The results are reproducible. But then the compound behaves differently in more complex models or clinical settings.

The quiet truth heard across pharmaceutical labs: using 2D cell models to determine drug efficacy and toxicity does not adequately address the complexity of real world 3D tissues. Cells growing in a monolayer on plastic experience conditions that simply don’t exist in actual organs or tumours. When researchers try to move beyond 2D cultures, they face a critical challenge: lack of tools for cellular phenotyping of ex vivo samples. Clinical biopsies are precious material that can’t be wasted on methods not designed for them. Tumouroids and organoids have thickness and complexity that traditional tools struggle to analyse. The very characteristics that make these models valuable also make them harder to work with.

The result? Many labs continue using 2D assays not because they provide better data, but because the alternatives seem too difficult. Experiments stall. Toxicity data remains unclear. The gap between laboratory findings and clinical outcomes persists.This isn’t a problem researchers can solve through better technique alone. It requires instrumentation designed for the realities of three-dimensional biology.

Why 3D samples provide more useful data

Biologically relevant 3D cell models provide more useful data than traditional 2D cultures. But why does dimension matter so much?

Ex vivo models help researchers gain insight into a drug’s mechanism of action and safety within a more physiologically relevant context than cell cultures. When you test a drug on cells growing flat on plastic, you’re studying biology that doesn’t exist in patients. When you test the same drug in ex vivo samples like clinical biopsies or tumouroids, you’re studying biology that actually resembles the tissue the drug will encounter.

3D samples like tumouroids and ex vivo clinical biopsies are more biologically relevant than traditional 2D cell assays because they retain structural complexity, cell-to-cell interactions and tissue architecture that influence how drugs actually work. A compound that appears effective in a monolayer might fail to penetrate a 3D structure. A drug that seems safe in 2D might trigger unexpected responses when cells interact in three dimensions.This isn’t just about making experiments more complicated. It’s about making data more predictive. The goal of drug development is to understand how compounds will behave in patients. Ex vivo systems move researchers closer to that reality. The challenge has been measuring these complex samples reliably. That’s where tool selection becomes critical.

Making ex vivo workflows work

Ex vivo workflows can actually improve efficiency when paired with the right tools, even though they appear more complex at first glance. The key is choosing instruments designed specifically for the samples you’re studying rather than trying to adapt tools built for 2D cultures. When you lack tools for cellular phenotyping of ex vivo samples, every experiment becomes trial and error. You spend time troubleshooting methods that were never designed for thick, irregular, three-dimensional samples. You waste precious clinical material on approaches that can’t capture the biology you need to see.

The right tools eliminate this friction. Instruments designed for ex vivo analysis accommodate sample complexity from the start. They’re built to handle the thickness, irregularity and physiological relevance that make 3D models valuable. This reduces the experimental iterations needed to generate meaningful data. Efficiency isn’t about shortcuts. It’s about matching tool capabilities to sample reality so researchers spend less time fighting their instruments and more time understanding biology.

Metabolic analysis in physiologically relevant context

Analysing drug efficacy and toxicity in ex vivo samples requires understanding how drugs affect cellular function in samples that retain three-dimensional structure. Traditional methods often require destroying the very architecture that makes ex vivo models valuable. The Agilent Seahorse XF Flex Analyser is designed for the analysis of ex vivo samples so researchers can gain insight into a drug’s mechanism of action and safety within a more physiologically relevant context than cell cultures. The system works with clinical biopsies, tumouroids and organoids without requiring tissue dissociation.

This matters because ex vivo models help researchers gain insight into drug mechanism of action and safety within a more physiologically relevant context than 2D cell cultures. By analysing intact tissue samples, researchers can assess how drugs affect cellular metabolism in conditions that actually resemble patient biology. The Seahorse XF Flex addresses the lack of tools for cellular phenotyping of ex vivo samples by providing metabolic profiling capabilities specifically designed for these challenging sample types.

24-well metabolic analyzer, Seahorse XF Flex Analyzer | Agilent

Practical applications:

Imaging deeper into 3D biology

Understanding cellular responses in ex vivo samples requires seeing into thick, complex structures. Traditional imaging approaches struggle with samples that extend beyond a few cell layers, forcing researchers to either section valuable material or accept surface-level data that misses critical biology.

The Agilent BioTek Cytation C10 Confocal Imaging Reader allows researchers to look deeper into thick sample biology with improved clarity and detail. The confocal imaging system addresses the lack of tools for cellular phenotyping of ex vivo samples by providing the depth resolution needed for three-dimensional structures.

This capability matters for drug development because biologically relevant 3D cell models provide more useful data when you can actually see what’s happening throughout the structure, not just on the surface. Cell migration, invasion and drug responses often vary by location within a tumouroid or tissue sample. Without appropriate imaging tools, researchers miss spatial information critical to understanding efficacy and toxicity.

The Cytation C10 enables cellular phenotyping of the ex vivo samples that provide physiologically relevant data for drug discovery.

Practical applications:

  • Image cell migration and invasion in 3D cancer models
  • Visualise drug distribution in thick tissue samples
  • Phenotype cellular responses throughout tumouroids and organoids
  • Analyse ex vivo clinical biopsies with depth resolution

Confocal High Content Imaging Microscope, BioTek Cytation C10 | Agilent

Science that respects biological reality

There’s a common mindset in drug discovery that researchers must accept the limitations of 2D models because ex vivo systems are too difficult. That working with clinical biopsies isn’t practical. That 3D cultures are too complex for routine use.

Chemetrix rejects this narrative.Researchers shouldn’t settle for models that don’t adequately address the complexity of real world 3D tissues. They shouldn’t compromise scientific rigour because tools weren’t designed for physiologically relevant samples. And they absolutely shouldn’t accept that predicting clinical outcomes requires choosing between feasibility and accuracy.

This is where partnership matters. Chemetrix doesn’t just supply instruments. We advocate for a scientific culture grounded in integrity, accuracy and respect for the complexity of living systems. When we say ex vivo models provide more useful data, we’re affirming that good science requires data that reflect real biology. The lack of tools for cellular phenotyping of ex vivo samples has been a barrier for too long. The Seahorse XF Flex and Cytation C10 aren’t just instruments. They’re commitments to removing barriers between researchers and the capabilities they need.

Chemetrix partners with researchers because they deserve solutions designed with biological reality in mind. Ex vivo systems that work reliably. Analysis that captures what matters. Support that helps labs implement physiologically relevant models confidently. This is how drug development advances: not through researchers heroically overcoming inadequate tools, but through systems that make biological relevance routine.

Better models, better medicines

Drug development doesn’t have to rely on models that don’t adequately address the complexity of real world 3D tissues. Biologically relevant 3D cell models provide more useful data. But only when you have tools designed for cellular phenotyping of ex vivo samples.

Ready to move beyond 2D limitations?

Discover how the Agilent Seahorse XF Flex enables analysis of clinical biopsies and 3D cultures. Explore how the Agilent BioTek Cytation C10 allows researchers to look deeper into thick sample biology with improved clarity and detail.

Contact Chemetrix to discuss how ex vivo workflows can improve the predictive value of your drug discovery research. Better models lead to better medicines. With the right partnership and the right tools, your lab can generate the clinically relevant data that truly matters.


✅ TL;DR – Key Takeaways

  • Using 2D cell models to determine drug efficacy and toxicity does not adequately address the complexity of real world 3D tissues
  • Ex vivo models help researchers gain insight into drug mechanism of action and safety within a more physiologically relevant context than cell cultures
  • 3D samples like tumouroids and ex vivo clinical biopsies are more biologically relevant than traditional 2D cell assays
  • The Seahorse XF Flex and Cytation C10 address the lack of tools for cellular phenotyping of ex vivo samples

How to Achieve 2-Minute Toxic Element Analysis with Integrated HPLC-ICP-MS

When regulatory limits for toxic elements in food keep getting stricter, labs face an uncomfortable reality: the methods they’ve relied on for years might not be fast enough or sensitive enough anymore. Analysis times stretching beyond 10 minutes per sample create bottlenecks. Coupling different instruments feels risky. And when your lab is responsible for detecting inorganic arsenic in baby food or cadmium in rice, there’s no room for error.

Here’s what most food testing labs don’t realise: the perceived complexity of coupling HPLC to ICP-MS is largely a myth. With the right hardware and software integration, what seems like a daunting technical challenge becomes a routine workflow that delivers results in under two minutes per sample.

The daily pressure of food safety testing

Walk into any food testing laboratory and you’ll hear the same concerns. Analysts are under pressure to process more samples with the same resources. Method development feels like reinventing the wheel for every new matrix. And when regulatory bodies lower action levels for toxic elements, labs scramble to validate new methods while maintaining daily sample throughput.

The real frustration? Many analysts believe that analysing inorganic arsenic, cadmium, lead and mercury requires complicated instrument coupling that only specialists can handle. They’ve heard that HPLC-ICP-MS is temperamental. They worry about stability over long sequences. They’re concerned that different vendors’ systems won’t communicate properly.These concerns create dangerous hesitation. Labs stick with older, slower methods because they’re familiar, even when those methods can’t meet new regulatory requirements. Sample backlogs grow. Turnaround times stretch.

The bottleneck isn’t the science. It’s the assumption that the solution has to be complicated.

Why toxic element speciation matters

Not all arsenic is created equal. Total arsenic measurements tell you how much is present, but they don’t tell you the critical part: is it toxic? Inorganic arsenic (the sum of arsenite As(III) and arsenate As(V)) is significantly more toxic than organic arsenic compounds like arsenobetaine found naturally in seafood. This is why regulations specify limits for inorganic arsenic rather than total arsenic. A rice cereal might contain arsenic, but if it’s all organic forms, the health risk is minimal. If it’s inorganic arsenic, even at low concentrations, it poses a developmental risk
to infants.

The same principle applies to other toxic elements. Cadmium accumulates in rice grown in contaminated soil. Lead and mercury, even at trace levels, affect neurological development in children. The US House of Representatives report in February 2021 found that many baby foods sold in supermarkets contained unacceptably high concentrations of these elements.

This is where speciation analysis becomes critical. HPLC separates different chemical forms of arsenic before ICP-MS detects them. By oxidising As(III) to As(V) during sample preparation, the analysis simplifies to measuring one peak representing total inorganic arsenic. The chromatographic separation happens in under two minutes, the ICP-MS provides sensitivity down to parts per billion and labs can confidently determine whether a food product meets regulatory limits.Food testing labs aren’t just generating data. They’re protecting the most vulnerable consumers: babies, infants and young children whose developing bodies are most susceptible to toxic element exposure.

 

Image credit: Institut für Analytische Chemie Universität Wien

The integration that changes everything

The breakthrough isn’t in the HPLC or the ICP-MS individually. Both instruments are well known in the industry for performance and robustness. The efficiency gain comes from how they work together. Agilent developed an optimised interface that physically couples the Agilent 1260 Inifinity III HPLC to both the 8900 ICP-QQQ and 7850 ICP-MS systems. But the real innovation is software integration. The entire coupled system is set up and operated from the ICP-MS MassHunter software. One interface. One method. Automated analysis.

Single software control means analysts don’t toggle between platforms or manually synchronise instrument parameters. Method development happens in one place.

Stable hardware coupling removes the guesswork from connecting instruments. The optimised interface ensures consistent sample transfer without leaks, dead volume or carryover issues.

Reduced setup time transforms HPLC-ICP-MS from a specialist technique into a routine capability. Labs new to speciation analysis can implement the method without extensive troubleshooting.

Fast 2-minute runs change the economics of compliance testing. When analysing inorganic arsenic requires 10+ minutes per sample using conventional columns, labs face real capacity constraints. At 2 minutes per sample, the same instrument processes five times the volume.

The 7850 ICP-MS adds practical features that matter for real-world food matrices. Ultra High Matrix Introduction (UHMI) handles samples with high dissolved solids without constant maintenance. The IntelliQuant function provides instant visibility into total matrix composition. And helium collision mode addresses spectral interferences without complex method optimisation.

Food safety compliance made routine

The US Baby Food Safety Act 2021 proposes maximum levels of 10-15 ppb inorganic arsenic depending on whether products are cereal-based. The FDA’s Closer to Zero plan phases in action levels for lead, arsenic, cadmium and mercury through 2024 and beyond. EU regulations specify limits for inorganic arsenic in rice between 0.1-0.3 mg/kg.

These aren’t aspirational targets. They’re enforceable limits that require labs to deliver accurate, defensible results.

The Agilent 1260 HPLC coupled to the Agilent 8900 ICP-QQQ provides the sensitivity and speed food testing labs need. The 8900 offers detection limits of 1.99 µg/kg for solid samples and 0.08 µg/L for liquid samples, well below regulatory action levels. The method complies with FDA Elemental Analysis Manual sections 4.7 and 4.11, as well as European standards EN16802:2016 and prEN17374:2019.

Real-world validation across baby foods, rice cereals, beverages and animal feed demonstrates recoveries between 82-111% with precision from 0.3-9.4% RSD.

📚 LEARN MORE: Application Note: Analysis of Inorganic Arsenic, Cadmium, Lead and Mercury in Baby Foods by ICP-MS (5994-3713EN)

Agilent 1260 Infinity III LC System

Agilent 7850 ICP-MS

High-throughput screening for production environments

Food manufacturers testing ingredients before use or finished products before release face a different challenge. They need screening capability that keeps pace with production schedules. Samples can’t wait days for results. Backlogs mean inventory sitting in quarantine.

The Agilent 1260 HPLC coupled to the Agilent 7850 ICP-MS delivers the throughput production labs require. The 7850 combines proven hardware with software features that simplify workflow for analysts who may be new to ICP-MS or new to Agilent systems. The 7850’s 10 orders of magnitude linear dynamic range means major and trace analytes are measured in a single run. No over-range failures. No sample reruns. The system processes samples with per cent-level total dissolved solids thanks to UHMI technology as standard.

For inorganic arsenic screening in rice cereals, the fast HPLC-ICP-MS method reduces analysis time from over 10 minutes to under 2 minutes. The short anion exchange column, optimised mobile phase and small injection volumes maintain baseline separation of inorganic arsenic from organic species without compromising resolution.

Empowering labs, not overwhelming them

There’s a pervasive mindset in many labs that complexity is just part of the job. That coupling instruments will always be difficult. That fast methods sacrifice accuracy. That meeting new regulatory limits requires hiring specialists or sending samples to reference labs.

Chemetrix rejects this narrative. Labs shouldn’t have to choose between speed and accuracy. They shouldn’t accept that advanced techniques are only accessible to experts. And they absolutely shouldn’t operate under the assumption that their current capabilities define their future possibilities.

This is where partnership matters. Chemetrix doesn’t just supply instruments. We advocate for a scientific culture grounded in integrity, accuracy and respect for the people doing the work. When we say the Agilent HPLC-ICP-MS coupling is easier than labs think, we’re not minimising the science. We’re affirming that with the right tools and support, routine labs can deliver extraordinary results.

The optimised interface, integrated software control and proven application methods aren’t just technical specifications. They’re a commitment to removing barriers between labs and the capabilities they need.

Conclusion

Toxic element analysis in food doesn’t have to be the bottleneck in your lab. The perceived complexity of HPLC-ICP-MS coupling dissolves when hardware and software are designed to work together from the start.


Ready to transform your toxic element analysis workflow?

Download the application notes for baby food and rice cereal analysis to see validated methods and real-world results. Contact Chemetrix to discuss how fast HPLC-ICP-MS screening can eliminate testing bottlenecks in your facility.

Food safety depends on labs that can deliver accurate results quickly. With the right partnership and the right tools, your lab can be exactly that kind of asset.

Contact Chemetrix today to discuss your toxic element analysis challenges and discover solutions designed for your reality.


✅ TL;DR – Key Takeaways

  • HPLC-ICP-MS coupling is simpler than most labs assume when using integrated Agilent systems
  • 2-minute analysis times for inorganic arsenic deliver 5x throughput vs conventional methods
  • Detection limits well below regulatory action levels ensure compliance confidence
  • Single software control reduces setup complexity and streamlines daily operation

Festive Water Safety: Lab Testing in SA

Why is water safety critical during South Africa’s festive season?

Summer in South Africa brings heat, travel, and thousands of holidaymakers to beaches, pools, and picnic spots. But the spike in water consumption, and pressure on water infrastructure, raises serious concerns. Ensuring the safety of drinking water and recreational waters during this period is essential to safeguard public health and support tourism.

 

🖥️ Watch the Detection of Microplastics using Thermoanalytical Methods webinar to learn about which analytical approach(es) offer the best results for PFAS in the environment.

The challenges of high-volume water testing during summer

As demand increases, testing labs face rising sample loads and tighter turnaround times. Detecting a range of contaminants, from microbial threats and industrial chemicals to PFAS (“forever chemicals”) and microplastics, requires sensitive, fast and reliable instrumentation. Traditional methods can struggle to keep up, leading to bottlenecks that may delay the detection of critical hazards. That’s where advanced instrumentation and workflow automation become indispensable.

 

🖥️ Watch the Analysis of PFAS: Strategies to Optimise Performance webinar to learn about which analytical approach(es) offer the best results for PFAS in the environment.

📚 Download the Guide to Targeted Quantification and Screening of PFAS Compounds in Environmental Matrices Primer to explore the basics and the regulatory framework for PFAS analysis.

Agilent water testing solutions: Speed, sensitivity, and scale

Agilent’s comprehensive water testing portfolio supports laboratories with state-of-the-art analytical tools, including:

Key Agilent Instruments for Water Quality Testing

  • Agilent Ultivo LC/MSMS – Ideal for ultra-trace PFAS and persistent organic pollutants in drinking and environmental water. Compact yet powerful, it supports high-throughput labs with limited space.
  • Agilent 6475 LC/MSMS – Offers sensitive, reproducible quantification of a wide range of contaminants in complex matrices.
  • Agilent 1290 Infinity III LC System – Delivers fast, reliable chromatographic separations critical to high-throughput analysis.
  • Agilent 8860 GC and Agilent 5977B GC-MSD – Combines rugged GC performance with high-sensitivity mass detection, ideal for volatile organic compound analysis.
  • InfinityLab PFC-Free HPLC Conversion Kit – Helps reduce PFAS background interference for cleaner data and better detection accuracy.
Together, these tools allow for simultaneous detection of pesticides, metals, PFAS, organic pollutants, and microbiological indicators in both drinking and recreational water samples.

Keeping communities and holidaymakers safe

South African municipalities, water boards, and private labs rely on fast, precise testing to ensure that public taps, swimming pools, and beaches remain safe during peak tourist periods. With Agilent’s integrated systems and automation-ready workflows, labs can handle seasonal surges efficiently, reducing wait times and delivering timely insights to stakeholders.
By enabling early detection and fast reporting, labs support both immediate public safety and long-term environmental health.

Ready to modernise your water testing workflows?

Whether you’re managing municipal water quality or testing surface water for environmental compliance, Agilent’s proven technologies and application support can help you handle festive season demand with confidence.

 


✅ TL;DR – Key Takeaways

  • South Africa’s festive season significantly increases demand for water testing.
  • Water contamination risks rise in both drinking supplies and recreational sources.
  • Agilent offers a suite of instruments for rapid, high-sensitivity testing (LC/MS, GC/MS, HPLC).
  • Automation-ready workflows improve throughput and reduce manual handling.
  • Accurate testing ensures public health, supports tourism, and builds trust in infrastructure.

Ensuring Accurate Consumer Product Testing: From Toys to Leather

Why is consumer product testing essential during the festive season?

As South Africans fill their homes with toys, gadgets and leather goods during the festive shopping rush, ensuring these products are safe and compliant is paramount. Testing labs play a vital role in verifying that everyday items meet stringent safety standards before reaching consumers.

The complexities of testing diverse consumer products

Consumer goods vary widely, from children’s toys requiring checks for harmful substances like phthalates and heavy metals, to leather handbags needing analysis of dyes and chemical residues. Accurate testing demands sophisticated analytical methods capable of identifying contaminants across a broad chemical spectrum.

🖥️ Watch the The PFAS Legacy in our Urban Environment webinar webinar to discover the key differences between LC/TQ and LC/Q-TOF and how are they used for providing information on PFAS in the environment.

How Agilent’s advanced analytical instruments support comprehensive testing

Agilent provides state-of-the-art solutions tailored for consumer goods testing, including chromatography and spectroscopy instruments such as LC/MS and GC/MS systems. These instruments allow labs to identify contaminants, measure chemical compositions, and perform high-throughput screening to maintain safety without sacrificing speed. Agilent’s robust platforms help laboratories meet tight deadlines during high-volume seasons.

📚 Download the Analysis of Short- and MediumChain Chlorinated Paraffins in Textiles and Leather Using Triple Quadrupole LC/MS Application Note for more stability and sensitivity during routine consumer testing laboratories. 

High-throughput workflows accelerate testing during peak demand

During high-volume shopping months, labs must clear large batches of consumer products swiftly without compromising safety. Agilent’s solutions integrate automation and streamlined workflows, helping labs increase throughput while maintaining accuracy. This ensures faster turnaround times, enabling retailers to confidently supply safe products to the market.

📚 Download the Phthalates Analysis in Toys using Agilent 5977E GC/MS Application Note that demonstrates good and a cost-effective solution to help test the six regulated phthalates in children’s toys.

Protecting consumers and brands through reliable testing

Accurate, timely testing safeguards not only consumer health but also brand reputation. Laboratories equipped with Agilent’s instruments can deliver consistent, validated results that help manufacturers and importers meet regulatory standards and build consumer trust.

Ready to enhance your consumer product testing capabilities?

Discover how Agilent’s comprehensive testing solutions can support your lab’s compliance needs and festive season workload.

 


TL;DR – Key Takeaways

  • Festive season shopping increases demand for consumer product testing in South Africa.
  • Testing covers toys, leather goods, textiles, and more for harmful substances and compliance.
  • Agilent’s LC/MS and GC/MS systems enable precise contaminant detection and chemical analysis.
  • High-throughput testing workflows ensure fast, accurate results during peak seasons.
  • Reliable testing protects consumer safety and brand reputation.

Keeping Holiday Tables Safe: Streamlining Agilent in South Africa

Why is food safety more challenging during South Africa’s festive season?

From lively braais to large family feasts, the holiday season means a surge in food production and consumption. This increase brings challenges in managing contaminants like pesticides on fresh produce or residues in packaged meats. Ensuring food safety is vital to protect public health and uphold brand reputation.

 

 

Challenges faced by labs during peak testing periods

High sample volumes and diverse food types place huge demands on testing labs. Manual sample preparation can slow down processes and increase errors, risking delays in identifying contaminants and potentially allowing unsafe food products to reach consumers.

 

How do Agilent LC/MS and GC/MS systems improve contaminant detection?

Agilent’s advanced Liquid Chromatography/Mass Spectrometry (LC/MS) and Gas Chromatography/Mass Spectrometry (GC/MS) platforms enable rapid, sensitive detection of pesticides, antibiotics, mycotoxins, and other harmful residues in complex food samples, ensuring accuracy even under pressure.

 

In one study, Agilent demonstrated its gas chromatography (GC) and mass spectrometry (MS) systems achieved “excellent linearity” in testing for over 200 pesticides across a wide dynamic range (0.1 to 5,000 ppb).

 

 

Agilent LC/MS & GC/MS instruments.

The role of automation in sample preparation

Raykol’s automated sample preparation systems help labs handle larger sample volumes consistently and quickly, reducing human error and freeing analysts to focus on data interpretation. This is critical when the pressure is on to deliver reliable results fast.

 

Raykol Automated Solid Phase Extraction system visual.

Why is real-time monitoring important for food safety during holidays?

Continuous quality control lets producers and retailers react promptly to contamination risks, protecting consumers and maintaining compliance with South African and international food safety regulations, especially critical during holiday spikes in demand.

 

 

How can producers and retailers stay compliant and build consumer trust?

Investing in cutting-edge testing technology and automation not only helps companies meet evolving regulatory requirements but also demonstrates a commitment to consumer safety, key for maintaining trust during high-visibility holiday seasons.

 

 

 

Upgrade your food safety testing workflows now

To keep holiday tables safe and operations smooth, labs and food suppliers should leverage Agilent’s LC/MS and GC/MS instruments alongside Raykol’s automated sample prep solutions.

 

 


TL;DR – Key Takeaways

  • Holiday season increases food safety testing demands in South Africa.
  • Manual prep and high sample loads create bottlenecks and risk errors.
  • Agilent LC/MS and GC/MS systems enable sensitive, fast contaminant detection.
  • Raykol automation speeds up sample prep, improving lab throughput and accuracy.
  • Real-time monitoring and robust workflows safeguard consumers and ensure compliance.